Eosinophils in allergic diseases: Immunopharmacological regulation

Immunopharmacology and Immunotoxicology

Volumn 19, Issue 4, 1997, Pages 405-423

  Ventura, M T ^a   Bruno, L M ^b   Iacobelli, A ^b   Tursi, A ^b  

^a UNIVERSITY OF BARI   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYTOKINE; EOSINOPHIL CATIONIC PROTEIN; FREE RADICAL; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MAJOR BASIC PROTEIN; NEUROTOXIN; PEROXIDASE;

ALLERGIC DISEASE; CELL GRANULE; CELL SECRETION; EOSINOPHIL; HUMAN; IMMUNOPHARMACOLOGY; INFLAMMATION; MEDIATOR RELEASE; ONTOGENY; PARASITOSIS; PRIORITY JOURNAL; REVIEW;

EOS;

EID: 0031426848     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979709007664     Document Type: Review

References (98)

1. Erlich, P., Uber die specifischen granulationes des blutes, Arch. Anat. Physiol. LP2.3, Physiol. Abt., 571, 1879
2. Jordana, M., Eosinophils controversies: is the end near? Mucosal Immunol. Update, 4: 41, 1996.
3. Butterworth, A.E., Cell-mediated damage to helminths, Adv. Parasitol., 23:143, 1984.
4. Butterworth, A.E., Wassom, D.L., Gleich, G.J. et al., Damage to schistosomula of schistosoma mansoni induced directly by eosinophil major basic protein, J.Immunol., 122:221, 1979.
5. Butterworth, A.E., Sturrock, R.F., Houba, V. et al, Eosinophils as mediators of antibody-dependent damage to schistosomula, Nature, 256:727, 1975.
6. Bousquet, J., Carres, P., Laciest, J. et al., Eosinophilic inflammation in asthma, New Engl. J. Med., 323:1033, 1990.
7. Corrigan, C.J., Kay, A.B., T cells and eosinophils in the pathogenesis of asthma, Immunol. Today, 13:501, 1992.
8. Desreumaux, P., Bloget, F., Seguy, D. et al., Interleukin 3, granulocyte macrophage colony-stimulating factor, and interleukin 5 in eosinophilic gastroenteritis , Gastroenterology, 110:768, 1996.
9. Gleich, G.J., Loegering, D.A., Immunobiology of eosinophils, Annu. Rev. Immunol., 2:429, 1984.
10. Gleich, G.H., The eosinophil: structure and biochemical composition, Am. J. Trop. Med. Hyg., 26:126, 1977.
11. Gleich, G.J., The eosinophils: new aspects and functions, J. Allergy Immunol., 60:73, 1977.
12. Gleich, G.H. Adolphson, C.R., The eosinophilic leucocyte: structure and function, Adv. Immunol., 39:177, 1986.
13. Venge, P., The eosinophil, In: Godard, P.H., Bousquet, J., Michel, F.B., eds, Advances in Allergology and Clinical Immunology, The Parthenon, Publ., Group, U.K., 175, 1992.
14. Fukuda, T., Gleich, G.H. , Heterogeneity of human eosinophils, J. Allergy Clin. Immunol., 83:369, 1989.
15. Prin, L., Charon, J., Capron, M., et al., Heterogeneity of human eosinophils II. Variability of respiratory burst activity related to cell density, Clin. Exp. Immunol., 57:735, 1984.
16. Gruart, V., Balloul, J.M., Prin, L, et al., Variation in protein expression related to human eosinophil heterogeneity, J. Immunol., 142:4416, 1989.
17. Sonoda, Y., Arai, N., Ogawa, M., Human regulation of eosinophilopoiesis in vitro: analysis of the targets of Interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF) and Interleukin-5, Leukemia, 3:14, 1989.
18. Capron, M., Spiegelberg, H.L., Prin, L., et al., Role of IgE receptor in effector function of human eosinophils, J. Immunol., 132:462, 1984.
19. Gleich, G.J., Adolphson, C.R., Leiferman, K.M., The biology of the eosinophilic leukocyte, Annu. Rev. Med., 44:85, 1993.
20. Springer, T.A., Adhesion receptors of the immune system, Nature, 346:425, 1990.
21. Warringa, R.A.J., Koenderman, L., Kok, P.T.M., et al., Modulation and induction of eosinophil chemotaxis by granulocyte-macrophage colony stimulating factor and Interleukin-3, Blood, 77:2694, 1991.
22. Sanderson, C.J., Interleukin-5, eosinophils and disease, Blood, 79:3101, 1992.
23. Capron, M., Eosinophils:receptors and mediators in hypersensivity, Clin. Exp. Allergy, 19:3, 1989.
24. Capron, M., Receptors and mechanism of activation of eosinophils in: Godard, P.H., Bousquet, J., Michel, F.B.,eds.,:Advances in allergology and clinical immunology The Parthenon Publ., Carnforth Park Ridge, 187, 1992.
25. Capron, M., Tomassini, M., Torpier, G. et al., Selectivity of mediators released by eosinophils, Int. Arch. Allergy Appl. Immunol., 88:54, 1989.
26. Hartnell, A., Moqbel, R., Walsh, G.M., et al, Fc gamma and CD11/CD18 receptor expression on normal density and low density human eosinophil, Immunology, 69:264, 1990.
27. Sanderson, C.G., Interleukin5, eosinophils and disease, Blood, 79: 3101, 1992.
28. Odgen, B.E., Hill, H.R., Histamine regulates lymphocyte mitogen responses through activation of specific H1 and H2 histamine receptor. Immunology, 41:107,1990.
29. Rafferty, P., Holgate, S.T., Histamine and its antagonists in asthma. J. Allergy Clin. Immunol., 84:144,1989.
30. Gleich, G.J., Loegering, D.A., Maldonado, J.E., Identification of a major basic protein in a Guinea pig eosinophil granules, J. Exp. Med., 137:1459,1973.
31. Wassom, D.L., Loegering, D.A., Solley, G.O. et al., Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia, J. Clin. Invest. 67:651, 1981.
32. Killey, W.V., Holley, K.E., Kephart, G.M. et al., Identification by immunofluorescence of eosinophil granule major basic protein in lung tissue of patients with bronchial asthma, Lancet, 2:11, 1982.
33. Gleich, G.J., Frigas, E., Loegering, D.A. et al., Citotoxic properties of the eosinophil major basic protein, J. Immunol., 123:2925, 1979.
34. Hastie, A.T., Loegering, D.A., Gleich, G.J. et al., The effect of purified human eosinophil major basic protein on mammalian ciliary activity, Am. Rev. Respir. Dis., 135:848, 1987.
35. Frigas, E., Loegering, D.A., Solley, G.O. et al., Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma, Mayo Clin. Proc., 56:345, 1981.
36. Gleich, G.J., The eosinophil and bronchial asthma: current understanding, J. Allergy. Clin. Immunol., 85:422, 1990.
37. O'Donnel, M.C., Ackerman, S.J., Gleich, G.J. et al., Activation of basophil and mastcell histamine release by eosinophil granule major basic protein, J. Exp. Med., 157:1981, 1983.
38. Durham, S.R., Loegering, D.A., Dunnette, S.L., Blood eosinophils and eosinophil derived proteins in allergic asthma, J. Allergy Clin. Immunology, 84:931, 1989.
39. Venge, P., Stromberg, A., Braconier, J.H. et al., Neutrophil and eosinophil granulocytes in bacterial infection: sequential studies on cellular and serum levels of granule proteins, Br. J. Haematol., 38:475, 1978.
40. Spry, C.J., Eosinophils in eosinophilic endomyocardial disease, Postgrad. Med. J., 62:609, 1986.
41. Tomassini, M., Magrini, L., De Petrillo, G. et al., Serum levels of eosinophils cationic protein in allergic diseases and natural allergen exposure, J. Allergy Clin. Immunol., 97:1350, 1996.
42. Dahl, R., Venge, P., Olsson, I., The content of eosinophil cationic protein in eosinophil leucocytes. Study on normal controls and patients with bronchial asthma, Allergy, 33:152, 1978.
43. Dahl, R., Venge, P., Olsson, I., Variations of blood eosinophils and ECP. Diurnal variation in normal subjects and patients with bronchial asthma: studies during inhalation challenge test, Allergy, 33:211, 1978.
44. Presentey, B., Ultrastructure of human eosinophils genetically lacking peroxidase, Acta Haematol., 71:334, 1984.
45. Agosti, J.M., Altman, L.C., Ayars, G.H. et al., The injurious effect of eosinophil peroxidase, hydrogen peroxidase, and halides on pneumocytes in vitro, J. Allergy Clin. Immunol., 79:496, 1987.
46. Jong, E.C., Mahmoud, A.A., Klebanoff, S.J., Peroxidase-mediated toxicity to schistosomula of schistosoma mansoni, J. Immunol., 126:468, 1981.
47. Jong, E.C., Henderson, W.R., Klebanoff, S.J., Bactericidal activity of eosinophil peroxidase, J. Immunol., 124:1378, 1980.
48. Jong, E.C., Klebanoff, S.J., Eosinophil-mediated mammalian tumor cell cytotoxicity: role of the peroxidase system, J. Immunol., 124:1949, 1980.
49. Henderson, W.R., Jong, E.C., Klebanoff, S.J., Binding of eosinophil peroxidase to mastcell granule with retention of peroxidasic activity, J. Immunol., 124:1383, 1980.
50. Nathan, C.F., Klebanoff, S.J., Augmentation of spontaneous macrophage-mediated cytolisis by eosinophil peroxidase, J. Exp. Med., 155:1291, 1982.
51. Henderson, W.R., Jong, E.C., Klebanoff, S.J., Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4 and D4, J. Immunol., 128:2609, 1982.
52. Henderson, W.R., Harley, J.B., Fauci, A.S., Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophil generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products, Immunology, 51:679, 1984.
53. Jorg, A., Henderson, W.R., Murphy, R.C. et al., Leukotriene generation by eosinophils, J. Exp. Med., 155:390, 1982.
54. Owen, W.F., jr., Soberman, R.J., Yoshimoto, T. et al., Synthesis and release of leukotriene C4 by human eosinophils, J. Immunol., 138:532, 1987.
55. Martin, L.B., Kita, H., Leiferman, K.M. et al., Eosinophils in allergy: role in disease, degranulation, and cytokines,Int. Arch. Allergy Immunol., 109:207, 1996.
56. Lilly, C.M., Chapman, R.W., Sehring, S.J. et al., Effects of interleukin 5-induced pulmonary eosinophilia on airway reactivity in the guinea pig. Am. J. Phisiol., 270:368,1996.
57. Venge, P., Hokansson, I., Peterson, C.G.B., Eosinophil activation in allergic diseases, Int. Archs. Allergy Appl. Immunol., 82:333. 1987.
58. Fabian, I., Kletter, Y., Mor, S. et al., Activation of human eosinophil and neutrophil functions by haematopoietic growth factors: comparisons of IL-1, IL-3, IL-5 and GM-CSF, British J. Haematol., 80:137, 1992.
59. Chihara, J., Plumas, J., Gruart, V., et al., Characterization of a receptor for Interleukin-5 on human eosinophils: variable expression and induction by granulocyte/macrophage colony-stimulating factor, J. Exp. Med., 172:1347, 1990.
60. Desreumaux, P., Capron, M., Immunobiology of eosinophils in mucosal tissue, Mucosal Immunol. Update ,4: 45,1996.
61. Yazdanbahsh, M., Eckmann, C.M., Roos, D., Characterization of the interaction of human eosinophils and neutrophils stimulated with opsonized zymosan, J. Immunol., 135:1378, 1985.
62. Koenderman, L., Tool, A.T.J., Roos, D. et al., Priming of the respiratory burst in human eosinophils is accompanied by changes in signal transduction, J. Immunol., 145:3883, 1990.
63. Fukuda, T., Ackerman, S.J., Reed, C.E. et al., Calcium ionophore A 231287 calcium-dependent cytolytic degranulation in human eosinophils, J. Immunol., 135:1349, 1985.
64. De Monchy, J.G., Kauffman, H.F., Venge, P. et al., Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions, Am. Rev. Resp. Dis., 131:373, 1985.
65. Metzer, W.J., Zavala, D., Richerson, H.B. et al., Local allergen challenge and bronchoalveolar lavage of allergic asthmatic lungs: description of the model and local airway inflammation, Am. Rev. Resp. Dis., 135:433, 1987.
66. Calderon, E., Lockey, R.F., A possible role for adhesion molecules in asthma, J. Allergy Clin. Immunol., 90:852, 1992.
67. Kloprogge, E., De Lecun, A.T., De Monchy, J.G.R. et al., Hypodense eosinophilic granulocytes in normal individuals and patients with asthma: generation of hypodense cell-populations in vitro, J. Allergy Clin. Immunol., 83:393, 1989.
68. Zoratti, E.M., Sedgwick , J.B., Vrtis, R.R. et al., The effect of platelet-activating factor and the generation of superoxide anion in human eosinophils and neutrophils, J. Allergy Clin. Immunol., 88:749, 1991.
69. Zeck-Kapp, G., Kroegel, C., Riede, U.N. et al., Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations, Allergy 50:34, 1995.
70. Dubucquoi, S., Desreumaux, P., Janin, A., et al., Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion, J. Exp. Med., 179:703,1994.
71. Schweizer, R.C., Van Kessel Welmers, B.A., Warringa, R.A. et al., Mechanisms involved in eosinophil migration. Platelet-activating induced - factor chemotaxis and interleukin-5-induced chemokinesis are mediated by different signals, J. Leukoc. Biol., 59:347, 1996.
72. Koryukina, I.P., Golovskaya, L.A., Sidorodov, D.V., Local eosinophilia of nasal mucus as a method of allergy determination, Mucosal Immunol. Update,4: 48, 1996.
73. Kojima, S., Yamamoto, N., Kanazawa, T. et al., Monoclonal IgE-dependent eosinophil cytotoxicity to haptenated schistosomula of schistosoma japonicum: enhancement of the cytotoxicity and expression of Fc receptors for IgE by Nippostrongylus brasiliensis infection, J. Immunol., 134:2719, 1985.
74. Caulfield, J.P., Lenzi, H.L., Elsan, P., Ultrastructure of the attack of eosinophils stimulated by blood mononuclear cell products on schistosomula of schistosoma mansoni, Am. J. Pathol., 120:380, 1985.
75. Anwar, A.R., Mc Kean, J.R., Smithers, S.R. et al., Human eosinophil - and neutrophil -mediated killing of schistosomula of schistosoma mansoni in vitro. Enhancement of complement dependent damage by mast-cell derived mediators and formyl methionyl peptides, J. Immunol., 124:1122, 1980.
76. Sher, A., Coffman, R.L., Hieny, S., et al., Ablation of eosinophil and IgE responses with anti-IL-5 or anti-IL-4 antibodies fails to affect immunity against schistosoma mansoni in the mouse, J. Immunol., 145:3911, 1990.
77. Mijamasu, M., Hirai, K., Takahashi, Y. et al., Chemotactic agonists induce cytokine generation in eosinophils, J. Immunol., 154:1339, 1995.
78. Broide, D.H., Firestein, G.S., Endobronchial allergen challenge in asthma. Demonstration of cellular source of granulocyte macrophage colony-stimulating factor by in situ hybridization, J. Clin. Invest., 88:1048, 1991.
79. Broide, D.H., Paine, M.M., Firestein, G.S., Eosinophils express Interleukin-5 and granulocyte macrophage-colony stimulating factor mRNA at sites of allergic inflammation in asthmatic, J. Clin. Invest., 90:1414, 1992.
80. Erger, R.A., Casale, T.B., Interleukin-8 is a potent mediator of eosinophil chemotaxis through endothelium and epithelium, Am. J. Physiol., 268:117, 1995.
81. Lukacs, N.W., Strieter, R.M., Shaklee, C.L. et al., Macrophage inflammatory protein-1α influences eosinophil recruitment in antigen-specific airway inflammation, Eur. J. Immunol., 25:245, 1995.
82. Shute, J.K., Lindley, I., Peichl, P. et al., Mucosal IgA is an important moderator of eosinophil responses to tissue-derived chemoattractants, Int. Arch. Allergy Immunol., 107:340, 1995.
83. Weber, M., Dahinden, C.A., Basophil and eosinophil activation by CC chemokines, Int. Arch. Allergy Immunol., 107:148, 1995.
84. Kameyoshi, Y., Dorschner, A., Mallet, A.I. et al., Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils, J. Exp. Med., 176:587, 1992.
85. Pazdrak, K., Schreiber, D., Forsythe, P. et al., The intracellular signal transduction mechanism of interleukin-5 in eosinophils: the involvement of lyn tyrosine kinase and the Ras-Raf-1-Mell-microtubule-associated protein kinase pathway, J. Exp. Med., 181:1827, 1995.
86. Wany, J.H., Duddle, J., Devalia, J.L. et al., Nitrogen dioxide increases eosinophil activation in the early-phase response to nasal allergen provocation, Int. Arch. Allergy Immunol., 107:103, 1995.
87. Lagente V., Pruniaux, M.P., Junien, J.L. et al., Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors, Am. J. Resp. Crit. Care Med., 151:1720, 1995.
88. Schwiebert, L.A., Beck, L.A., Stellato, C. et al., Glucocorticosteroid inibition of cytokine production: relevance to antiallergic actions, J. Allergy Clin. Immunol., 97:143, 1996.
89. Sanz, M.J., Weg, U.B., Walsh, D.T. et al., Differential effects of the PAF receptor antagonist UK-74,505 on neutrophil and eosinophil accumulation in Guinea-pig skin, Brit. J. Pharmacol., 113:513, 1994.
90. Erger, R.A., Casale, T.B., Comparative studies indicate that Platelet-activating-factor is a relatively weak eosinophilotactic mediator, Am. J. Resp. Cell. Mol. Biol., 12:65, 1995.
91. Kay, A.B., Inflammatory cells in bronchial asthma, J. Asthma, 26:335,1989.
92. Kelly, J., Cytokines of the lung, Am. Rev. Respir. Dis., 141:765,1990.
93. Wong, D.T.V., Weller, P.F., Galli, S.J., et al., Human eosinophils express transforming growth factor α, J. Exp. Med., 72:673,1990.
94. Costa, J.J., Matossian, R., Resnick, M.B. et al., Human eosinophils can express the cytokines tumor necrosis factor-alpha and macrophage inflammatory protein-1-alpha, J. Clin. Invest., 91:2673,1993.
95. Finotto, S., Ohno, I., Gauldie, J.S. et al., TNF-alpha production by eosinophils in upper airways inflammation (nasal polyposis), J. Immunol., 153:2278,1994.
96. Lukacs, N.W., Stricter, R.M., Shaklee, C.L. et al., Macrophage inflammatory protein1α influences eosinophil recruitment in antigen-specific airway inflammation, Eur. J. Immunol., 25:245,1995.
97. Cruikshank, K.K., Long, A., Tarpy, R.E., et al., Early identification of Interleukin-16 (Lymphocyte Chemoattractant Factor) and Macrophage Inflammatory Protein1α (MIP1α) in Broncoalveolar Lavage Fluid of antigen-challenged asthmatics Am. J. Respir. Cell. Mol. Biol., 13:738,1995.
98. Kita, H., The eosinophil: a cytokine producing cell?, J. Allergy Clin. Immunol., 97:889,1996.